Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Reducing safety-related drug attrition: the use of in vitro pharmacological profiling
Authors
Keywords
-
Journal
NATURE REVIEWS DRUG DISCOVERY
Volume 11, Issue 12, Pages 909-922
Publisher
Springer Nature
Online
2012-11-30
DOI
10.1038/nrd3845
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Can we discover pharmacological promiscuity early in the drug discovery process?
- (2012) Jens-Uwe Peters et al. DRUG DISCOVERY TODAY
- The determination and interpretation of the therapeutic index in drug development
- (2012) Patrick Y. Muller et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation
- (2012) Gül Erdemli et al. Frontiers in Pharmacology
- The ‘overly-sensitive’ heart: sodium channel block and QRS interval prolongation
- (2011) Gary A Gintant et al. BRITISH JOURNAL OF PHARMACOLOGY
- On the relationship between block of the cardiac Na+channel and drug-induced prolongation of the QRS complex
- (2011) AR Harmer et al. BRITISH JOURNAL OF PHARMACOLOGY
- How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?
- (2011) HG Laverty et al. BRITISH JOURNAL OF PHARMACOLOGY
- Simulation of multiple ion channel block provides improved early prediction of compounds’ clinical torsadogenic risk
- (2011) Gary R. Mirams et al. CARDIOVASCULAR RESEARCH
- In Silico Predictions of hERG Channel Blockers in Drug Discovery: From Ligand-Based and Target-Based Approaches to Systems Chemical Biology
- (2011) Olivier Taboureau et al. COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING
- Transformation ofin vitrotools for kinase profiling: keeping an eye over the off-target liabilities
- (2011) Kun Bi et al. Expert Opinion on Drug Discovery
- BindingDB and ChEMBL: online compound databases for drug discovery
- (2011) Anne Mai Wassermann et al. Expert Opinion on Drug Discovery
- Computational methods for early predictive safety assessment from biological and chemical data
- (2011) Florian Nigsch et al. Expert Opinion on Drug Metabolism & Toxicology
- Drugs with anticholinergic properties: a current perspective on use and safety
- (2011) Philip Gerretsen et al. Expert Opinion On Drug Safety
- Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease
- (2011) Sreemanti Basu et al. IMMUNOLOGIC RESEARCH
- Minimum information about a bioactive entity (MIABE)
- (2011) Sandra Orchard et al. NATURE REVIEWS DRUG DISCOVERY
- Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes
- (2011) Thomas Force et al. NATURE REVIEWS DRUG DISCOVERY
- Activity profiles of 309 ToxCast™ chemicals evaluated across 292 biochemical targets
- (2011) Thomas B. Knudsen et al. TOXICOLOGY
- Renaissance of ion channel research and drug discovery by patch clamp automation
- (2010) Niels Fertig et al. Future Medicinal Chemistry
- Genome-wide association study of PR interval
- (2010) Arne Pfeufer et al. NATURE GENETICS
- The predictive validity of the rat self-administration model for abuse liability
- (2010) Eoin C. O’Connor et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- An evaluation of hERG current assay performance: Translating preclinical safety studies to clinical QT prolongation
- (2010) Gary Gintant PHARMACOLOGY & THERAPEUTICS
- Cardiovascular Effects in Rats following Exposure to a Receptor Tyrosine Kinase Inhibitor
- (2010) Shirley A. Aguirre et al. TOXICOLOGIC PATHOLOGY
- Cardiotoxicity Associated with Targeting Kinase Pathways in Cancer
- (2010) Howard R. Mellor et al. TOXICOLOGICAL SCIENCES
- Translation of flecainide- and mexiletine-induced cardiac sodium channel inhibition and ventricular conduction slowing from nonclinical models to clinical
- (2010) B.M. Heath et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Pharmacological Promiscuity: Dependence on Compound Properties and Target Specificity in a Set of Recent Roche Compounds
- (2009) Jens-Uwe Peters et al. ChemMedChem
- Translational Toxicology and the Work of the Predictive Safety Testing Consortium
- (2009) WB Mattes et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- In vitrosafety pharmacology profiling: what else beyond hERG?
- (2009) Jacques Hamon et al. Future Medicinal Chemistry
- Parallel Functional Activity Profiling Reveals Valvulopathogens Are Potent 5-Hydroxytryptamine2B Receptor Agonists: Implications for Drug Safety Assessment
- (2009) X.-P. Huang et al. MOLECULAR PHARMACOLOGY
- The future of endocannabinoid-oriented clinical research after CB1 antagonists
- (2009) Bernard Le Foll et al. PSYCHOPHARMACOLOGY
- Blockade of the IKs potassium channel: An overlooked cardiovascular liability in drug safety screening?
- (2009) Rob Towart et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Physiochemical drug properties associated with in vivo toxicological outcomes
- (2008) Jason D. Hughes et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Can the anti-inflammatory potential of PDE4 inhibitors be realized: guarded optimism or wishful thinking?
- (2008) M A Giembycz BRITISH JOURNAL OF PHARMACOLOGY
- PDE4 inhibitors: current status
- (2008) D Spina BRITISH JOURNAL OF PHARMACOLOGY
- 5-HT1A Receptor, an Old Target for New Therapeutic Agents
- (2008) Enza Lacivita et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Drug-induced serotonin syndrome: a review
- (2008) Christina Sun-Edelstein et al. Expert Opinion On Drug Safety
- Cardiac sodium channels and inherited electrophysiologic disorders: a pharmacogenetic overview
- (2008) Jeroen PP Smits et al. EXPERT OPINION ON PHARMACOTHERAPY
- Effectiveness of benzodiazepines: do they work or not?
- (2008) Malcolm Lader Expert Review of Neurotherapeutics
- Adenosine and its receptors: Multiple modulatory functions and potential therapeutic targets for neurologic disease
- (2008) E. E. Benarroch NEUROLOGY
- In Silico Tools for Sharing Data and Knowledge on Toxicity and Metabolism: Derek for Windows, Meteor, and Vitic
- (2008) Carol A. Marchant et al. TOXICOLOGY MECHANISMS AND METHODS
- Drug Insight: selective agonists and antagonists of the glucocorticoid receptor
- (2008) Andrew McMaster et al. Nature clinical practice. Endocrinology & metabolism
- Scientific review and recommendations on preclinical cardiovascular safety evaluation of biologics
- (2008) Hugo M. Vargas et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Safety and secondary pharmacology: Successes, threats, challenges and opportunities
- (2008) Jean-Pierre Valentin et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
- Optimisation and validation of a medium-throughput electrophysiology-based hNav1.5 assay using IonWorks™
- (2007) A.R. Harmer et al. JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now